Therefore, in this study, we aimed to identify PIK3CA mutations in CMT samples, establish novel CMT cell lines characterized with PIK3CA mutations, and examine the in vitro anticancer effects of alpelisib on these cell lines. Here, PIK3CA is linked to Charcot-Marie-Tooth disease.